Elevation Oncology Inc at JMP Securities Hematology Oncology Summit (Virtual) Transcript
Good morning, everybody. Welcome to our annual JMP hematology and oncology conference. My name is Silvan Türkcan. I'm a senior analyst here at JMP Securities at Citizen covering precision medicines. It's my pleasure today to host, Shawn Leland, founder and CEO of Elevation Oncology. Thank you very much for joining us today.
Once again, thanks, Silvan, and thanks to the JMP team for hosting us.
Questions & Answers
Great. Could you please summarize your approach in targeted oncology and how you think about these oncogenic drivers?
Yeah, thanks for the questions, Silvan. So our approach to pursuing precision oncology targets is really to focus on true oncogenic drivers. I mean, I think there's a lot of discussion out there in the precision oncology community in
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |